Evidence-based medicine and antiepileptic drugs

Epilepsia

Volumn 40, Issue SUPPL. 5, 1999, Pages s47-s56

  Privitera, Michael D ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Antiepileptic drugs; Epilepsy; Evidence based medicine; Meta analysis; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; LAMOTRIGINE; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

DRUG INFORMATION; DRUG RESEARCH; EPILEPSY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL INFORMATION; META ANALYSIS; PRIORITY JOURNAL; REVIEW;

EID: 0032826647     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00919.x     Document Type: Review

References (37)

1. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone, 1997.
2. LeLorier J, Gregorie G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized controlled trials. N Engl J Med 1997;337:536-42.
3. Zuger A. New way of doctoring: by the book. NY Times 1997;B11.
4. Lau J, Ioannidis HP, Schmid CH. Summing up evidence: one answer is not always enough. Lancet 1998;351:123-7.
5. Greenhalgh T. Papers that summarise other papers (systematic reviews and meta-analyses). BMJ 1997;315:672-5.
6. Walker MC, Sander JWAS. Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs. Neurology 1997;49:333-7.
7. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313:145-51.
8. Mattson RH, Cramer JA, Collins JF, and the Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valporate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765-71.
9. Brodie MJ, Richens A, Yuen AEC, et al. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9.
10. Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996;313: 1169-74.
11. Bailar JC. The problems and promise of meta-analysis. N Engl J Med 1997;337:559-61.
12. Cramer JA, Mattson RH, Scheyer RD. New antiepileptic drugs [Letter]. Epilepsia 1998;39:233-4.
13. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-80.
14. US Gabapentin Study Group No 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo controlled, parallel-group study. Neurology 1993;43:2292-8.
15. Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group. Epilepsia 1994;35:795-801.
16. Sivenius J, Kalviainen R, Ylinen A, Riekkinen P. Double blind study of gabapentin in the treatment of partial seizures. Epilepsia 1991;32:539-42.
17. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990;335:1114-7.
18. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. US Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology 1993;43:2284-91.
19. Binnie CD, Debets RM, Engelsman M, et al. Double-blind cross-over trial of lamotrigine (Lamictal) as add on therapy in intractable epilepsy. Epilepsy Res 1989;4:222-9.
20. Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989;30:356-63.
21. Loiseau P, Yuen AW, Duche B, Menager T, Arne Bes MC. A randomised double blind placebo controlled crossover add on trial of lamotrigine in patients with treatment resistant partial seizures. Epilepsy Res 1990;7:136-45.
22. Messenheimer J, Ramsay RE, Willmore LJ, et al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994;35:113-21.
23. Schapel GJ, Beran RG, Vajda FJ, et al. Double blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry 1993;56:448-53.
24. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
25. Uthman BM, Rowan AJ, Ahmann PA, et al. Tiagabine for complex partial seizures. Arch Neurol 1998;55:56-62.
26. Sachdeo RC, Leroy RF, Krauss GL, et al. Tiagabine therapy for complex partial seizures. A dose-frequency study. Arch Neurol 1997;54:595-601.
27. Faught E, Wilder BJ, Ramsay E, et al. Topiramate controlled dose ranging trial in refractory partial epilepsy using 200, 400 and 600 mg daily dosages. Neurology 1996;46:1685-90.
28. Tassinari CA, Michelucci R, Chauvel P, et al. Double blind placebo controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763-8.
29. Sharief M, Viteri C, Ben-Menachem E, et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996;25:217-24.
30. Ben-Menachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-43.
31. Privitera M, Fincham R, Renry J, et al. Topiramate placebo controlled trial in refractory partial epilepsy using 600, 800 and 1000 mg daily dosages. Neurology 1996;46:1678-83.
32. The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures, Neurology 1995;45:224-30.
33. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures. Neurology 1998;51: 48-55.
34. Willmore J, Shu V, Wallin B, and the M88-194 Study Group. Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. Neurology 1996;46:49-53.
35. Elferink AJA, Van Zwieten-Boot BJ. Analysis based on number needed to treat shows differences between drugs studied [Letter]. BMJ 1997;314:603.
36. Moore A, McQuay H, Gray M (eds). Anticonvulsant NNTs. Bandolier 1998;54:4-5,
37. Oxman AD, Clarke MJ, Stewart LA. From science to practice. Meta-analyses using individual patient data are needed [Editorial; Comment]. JAMA 1995;274:845-6.